Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David McDermott
Beth Israel Deaconess Medical Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bristol-Meyers Squibb
Other : Compensation for Advisory Board participation
NA
DF/HCC Kidney Cancer SPORE
This SPORE is focused on several important themes in kidney cancer: 1) using the growing understanding of kidney cancer biology to target critical pathways and produce durable clinical benefit for patients with advanced kidney cancer; 2) correlating genomic analyses with clinical outcomes to identify molecular biomarkers for the purposes of monitoring and predicting treatment outcome; 3) understanding the mechanisms by which kidney cancer becomes resistant to standard therapies and developing effective treatment combinations.
Filed on October 01, 2015.
Tell us what you know about David McDermott's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David McDermott filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David McDermott | Beth Israel Deaconess Medical Center | Conflict of Interest | Array BioPharma | $10,000 - $19,999 |
| David McDermott | Beth Israel Deaconess Medical Center | Conflict of Interest | Merck Sharp & Dohme Corp | $5,000 - $9,999 |
| David McDermott | Beth Israel Deaconess Medical Center | Conflict of Interest | Merck Sharp & Dohme Corp | $5,000 - $9,999 |
| David McDermott | Beth Israel Deaconess Medical Center | Conflict of Interest | Novartis | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.